The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors
- Resource Type
- Article
- Source
- In
Lung Cancer December 2021 162:36-41 - Subject
- Language
- ISSN
- 0169-5002